OSUR Orasure Technologies Inc

$4.24 -5.15%

Healthcare · Surgical & Medical Instruments & Apparatus

Orasure Technologies Inc (OSUR) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $292 million. Shares last traded at $4.24, 7.3% below their 52-week high. Over the past year the stock is up 50.6%. Net profit margin is -59.8%, below the peer median of -7.6%. Revenue declined 38.1% year over year.

Market Cap

$292M

Shares Out

68.8M

EPS (TTM)

$-1.68

P/E Ratio

—

P/S Ratio

2.54

P/B Ratio

0.93

Dividend / Share

—

Dividend Yield

—

52-Week High

$4.58

52-Week Low

$2.09

Volume

70,006

Avg Vol (3m)

43,390.841

Performance

+1.19%

+37.22%

+45.21%

+75.21%

YTD

+77.41%

+50.62%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

60.81

SMA (50)

$3.47

SMA (200)

$2.98

Price vs SMA50

+22.36%

Price vs SMA200

+42.28%

ATR (14)

$0.22

Financials

Revenue

$115M

Net Income

$-69M

Gross Margin

41.9%

Operating Margin

-62.6%

Net Margin

-59.8%

Return on Equity

-21.9%

Return on Assets

-18.1%

Current Ratio

5.46

Debt / Equity

0.21

Revenue Growth (YoY)

-38.1%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-0.32	2026-05-08
FY 2025	$-0.94	2026-03-09
Q3 2025	$-0.67	2025-11-05
Q2 2025	$-0.48	2025-08-06
Q1 2026	$-0.21	2026-05-08
FY 2025	$-0.26	2026-03-09

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

OSUR vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap.

P/S vs peers

2.54 / 2.52 med

+1% premium

Net margin vs peers

-59.8% / -7.6% med

below median

1–14 of 14


SYK	Stryker Corporation	$118.1B	36.38	4.70	12.9%	+2.28%
MMM	3M	$83.9B	25.82	3.36	13.0%	+1.10%
BSX	Boston Scientific	$67.3B	23.27	3.35	14.4%	+0.64%
BDX	Becton Dickinson	$39.7B	23.64	1.82	7.7%	+1.62%
MDLN	Medline Inc.	$29.4B	—	—	—	-1.47%
DXCM	DexCom	$28.0B	33.43	6.00	17.9%	+1.69%
RMD	ResMed	$27.4B	19.53	5.32	27.2%	+1.24%
WST	West Pharmaceutical Services	$23.2B	46.92	7.54	16.1%	+1.35%
SOLV	Solventum	$13.1B	—	—	—	+1.21%
PEN	Penumbra Inc	$12.5B	70.18	8.88	12.7%	+0.28%
GMED	Globus Medical Inc	$10.8B	19.99	3.66	18.3%	+5.00%
BAX	Baxter International	$10.3B	-10.74	0.91	-8.5%	+2.58%
PODD	Insulet Corporation	$10.1B	40.84	3.73	9.1%	+1.51%
GKOS	Glaukos Corp	$7.7B	-40.92	15.13	-37.0%	+2.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.